Preventive Vaccines Market, By Vaccine Type (Live/Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vector Vaccines, and DNA Vaccines), By Disease Type (Pneumococcal, Poliovirus, Hepatitis, Influenza, Measles, Mumps and Rubella (MMR), Varicella, Human Papilloma Virus, and Other Disease Types), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Vaccine is a biological preparation such as medicine or drugs that stimulates immunity to a particular pathogen and this are administered to a person who can get targeted for infection.  Such vaccines consist of an agent that bear a rebalance to a disease-causing microorganism and helps to declining or killed infection. It’s also help to immune system to fight infections faster and more effectively, after taking vaccine it triggers the immune response, and help body to fight off the germ and decline the chance of ever enters again. The vaccines are made of very small amounts of weak or dead germs, they won’t make you sick. In simple word the vaccines do an incredible job of defensive from serious diseases like whooping cough and measles. Preventive Vaccines are generally used to prevent diseases like polio, chicken pox, measles, mumps, rubella, influenza (flu), and hepatitis A and B.

Increasing prevalence of infectious diseases is major factor boosting the growth for target market. Nowadays vaccines protect life’s of millions people worldwide from infectious diseases. In addition infectious diseases are measured as world’s extreme killers and also it is most significant health and security threats faced by the global community and vaccines play a key role to decreases such prevalence of infectious diseases. Such factors are propelling the demand for preventative vaccine globally. For instance, according to the World Health Organization (WHO), vaccination prevents 2-3 million deaths each year, and also state that they are sure that vaccines have saved millions of lives, and state that calculating an exact number is impossible. Additionally, growing government support for vaccine development is an important factor to fueling the demand for preventative vaccine. Government are taking initiatives to provide better life, therefore the government in many nation provide free vaccine to prevent from many diseases such as polio and many others which trigger the market growth. However, the factor such as high cost of vaccine development restraining the market growth. Furthermore the preventive vaccines has reached at the maturity in some of the disease such as polio, chicken pox, measles, mumps, rubella, influenza. Some of the vaccines are on the way for some diseases to establish itself in the market therefore such addition of new vaccines in the market will provide a huge growth opportunity to the target market.

The global preventive vaccines market is segmented based vaccine type, by disease type and region.

On the basis of vaccines type, the global preventive vaccines market is segmented live/attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vector vaccines, and DNA vaccines. Live/Attenuated Vaccines is expected to dominate the target market, there are many different of Live/Attenuated Vaccines available in the market also this vaccine represent one of the first successful methods of vaccination. It helps to save the life of millions of people from long time. For instance, according to Emory University, in the U.S., type of Live/Attenuated Vaccines reduced the incidence of measles by 99% and is projected to have prevented 52 million infections and 5,200 deaths in the first 20 years of use. On the basis of disease type, the target market is classified into pneumococcal, poliovirus, hepatitis, influenza, measles, mumps and rubella (MMR), Varicella, Human Papilloma Virus, and Other Disease Types.

Regional Insights:

Based on region the global preventive vaccines market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominate the target market, owing to the U.S. has one of the important healthcare systems in the world. High investment in research and development, with government initiatives to provide better lifestyle and lowering the impact of infectious diseases such factor propel the growth of target market in the region. Asia Pacific is expected to show highest CAGR in forecast period. Due to increasing in health care expenditure, with rising prevalence of infection diseases.

Detailed Segmentation:

Global Preventive Vaccines Market, By Vaccines type:

• Live/Attenuated Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Conjugate Vaccines
• Recombinant Vector Vaccines
• DNA Vaccines

Global Preventive Vaccines Market, By Disease Type:

• Pneumococcal
• Poliovirus
• Hepatitis
• Influenza
• Measles
• Mumps and Rubella (MMR)
• Varicella, Human Papilloma Virus
• Other Disease Types

Global Preventive Vaccines Market, By Region:

• • • North America
      • North America Preventive Vaccines Market, By Vaccines type
      • North America Preventive Vaccines Market, By Disease Type
      • North America Preventive Vaccines Market, By Country
        • U.S.
        • Canada
    • Europe
      • Europe Preventive Vaccines Market, By Vaccines type
      • Europe Preventive Vaccines Market, By Disease Type
      • Europe Preventive Vaccines Market, By Country
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Asia Pacific Preventive Vaccines Market, By Vaccines type
      • Asia Pacific Preventive Vaccines Market, By Disease Type
      • Asia Pacific Preventive Vaccines Market, By Country
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific                                                                                                                                                                                          
    • Latin America
      • Latin America Preventive Vaccines Market, By Vaccines type
      • Latin America Preventive Vaccines Market, By Disease Type
      • Latin America Preventive Vaccines Market, By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Middle East & Africa Preventive Vaccines Market, By Vaccines type
      • Middle East & Africa Preventive Vaccines Market, By Disease Type
      • Middle East & Africa Preventive Vaccines Market, By Country
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating the global Preventive vaccines market involves Astellas Pharma Inc., CSL Limited, Emergent BioSolutions, Inc., GlaxoSmithKline plc, Johnson & Johnson, MedImmune, LLC, Merck & Co., Inc., Pfizer, Inc., Sanofi Pasteur, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo, Biological E, and Panacea Biotec. The key players in the market are focusing on merge, partnership, and acquisition, with strong focused on research and development for product innovation for new diseases. For instance, on February 2017, Astellas and Affinivax announce universal partnership for MAPS vaccine targeting Pneumococcal Disease.

• Astellas Pharma Inc.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• CSL Limited
• Emergent BioSolutions, Inc.
• GlaxoSmithKline plc
• Johnson & Johnson
• MedImmune, LLC
• Merck & Co., Inc.
• Pfizer, Inc.
• Sanofi Pasteur
• Serum Institute of India Pvt. Ltd.
• Bavarian Nordic
• Mitsubishi Tanabe Pharma Corporation
• Daiichi Sankyo
• Biological E
• Panacea Biotec

“*” marked represents similar segmentation in other categories in the respective section